547 filings
Page 3 of 28
8-K
9sd ugr88v08y
19 Oct 22
ProPhase Labs Announces Collaboration with G42 Healthcare
8:05am
8-K
l3p0r
7 Oct 22
Departure of Directors or Certain Officers
6:15am
8-K
sygccxl
11 Aug 22
ProPhase Labs Announces Record Second Quarter 2022 Financial Results
9:05am
8-K
j4k90ynd
26 Jul 22
ProPhase Labs Announces New $6 Million Stock Repurchase Plan
8:15am
8-K
a3zmh qxld6ssfn8
21 Jul 22
ProPhase Labs Announces Licensing of New Investigational Cancer Compounds
8:35am
8-K
cdjvv
19 Jul 22
Regulation FD Disclosure
8:35am
8-K
7t6jj2p4
1 Jul 22
Changes in Registrant's Certifying Accountant
6:03am
8-K
89a9ul
28 Jun 22
ProPhase Labs Announces Formation of ProPhase BioPharma, Inc. (PBIO) for the Licensing and Development of Novel Drugs, Compounds and Biotechnology
8:35am
8-K
1vunk2uiojq48au6a
13 Jun 22
ProPhase Labs Announces Significant Laboratory Expansion
9:32am
S-8
mesu7y2
27 May 22
Registration of securities for employees
5:29pm
8-K/A
es20m5 8vudoy
23 May 22
Departure of Directors or Certain Officers
4:15pm
8-K
x4f ha8yagib600ml7
20 May 22
Departure of Directors or Certain Officers
4:05pm
8-K
0fllhqt njb
13 May 22
ProPhase Labs Announces Record First Quarter 2022 Financial Results
10:07am
8-K
lwh9cq28a9qbj86dzp2u
10 May 22
ProPhase Labs Announces Appointment of Bill White as Chief Financial Officer
9:22am
8-K
z47ej4 8cso35n4s
30 Mar 22
ProPhase Labs Announces Record Financial Results
8:46am
8-K
r2oqy c4v
2 Mar 22
Entry into a Material Definitive Agreement
4:26pm